Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-06
2006-06-06
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S192000, C548S190000, C514S370000
Reexamination Certificate
active
07056939
ABSTRACT:
The present invention relates to a new compound of formula I as a free base or a pharmaceutically acceptable salt thereof, a process for the preparation, pharmaceutical formulations containing said therapeutically active compound and to the use of said compound in therapy.
REFERENCES:
patent: WO-00/26203 (2000-05-01), None
patent: WO 200026203 (2000-05-01), None
Berg Stefan
Hellberg Sven
Astrazeneca AB
Barker Michael P.
White & Case LLP
LandOfFree
4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3636014